2003
DOI: 10.1037/0021-843x.112.3.393
|View full text |Cite
|
Sign up to set email alerts
|

The time course and significance of cannabis withdrawal.

Abstract: Withdrawal symptoms following cessation of heavy cannabis (marijuana) use have been reported, yet their time course and clinical importance have not been established. A 50-day outpatient study assessed 18 marijuana users during a 5-day smoking-as-usual phase followed by a 45-day abstinence phase. Parallel assessment of 12 ex-users was obtained. A withdrawal pattern was observed for aggression, anger, anxiety, decreased appetite, decreased body weight, irritability, restlessness, shakiness, sleep problems, and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

17
348
1
2

Year Published

2004
2004
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 395 publications
(368 citation statements)
references
References 43 publications
17
348
1
2
Order By: Relevance
“…The presence and magnitude of specific withdrawal symptoms were assessed using a version (17 items) of our Withdrawal Symptom Checklist, which includes common symptoms of both cannabis and tobacco withdrawal (Budney et al, 1999(Budney et al, , 2001(Budney et al, , 2003Hughes 2007). Each symptom was rated on a 0-3 scale (0 = not at all, 1= mild, 2 = moderate, 3 = severe) based on their experience during their recent period of abstinence.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The presence and magnitude of specific withdrawal symptoms were assessed using a version (17 items) of our Withdrawal Symptom Checklist, which includes common symptoms of both cannabis and tobacco withdrawal (Budney et al, 1999(Budney et al, , 2001(Budney et al, , 2003Hughes 2007). Each symptom was rated on a 0-3 scale (0 = not at all, 1= mild, 2 = moderate, 3 = severe) based on their experience during their recent period of abstinence.…”
Section: Methodsmentioning
confidence: 99%
“…The primary outcome measure, the Withdrawal Discomfort Score (WDS), was calculated by totaling scores from 9 items previously reported as common symptoms of withdrawal for both cannabis and tobacco: aggression, anger, appetite change (decreased for Cannabis, increased for Tobacco), depressed mood, irritability, anxiety/nervousness, restlessness, sleep difficulty, strange dreams (APA, 2000; Budney et al, 2004;Hughes, 2007;Vandrey et al, 2008). Prior studies have demonstrated that the individual Checklist items and the WDS scores change over time following abrupt cessation in a manner consistent with a true withdrawal syndrome (Budney et al, 2003(Budney et al, , 2004Hughes 2007), and the WDS has shown good internal consistency, α=.89 (Budney et al, 1999).…”
Section: Methodsmentioning
confidence: 99%
“…A breadth of laboratory-based studies have identified sleep disturbance as a salient symptom of cannabis withdrawal [43][44][45][46]. Controlled studies have shown that sleep disturbances increase during periods of abstinence and remit during periods of cannabis use [43].…”
Section: Sleep Disturbance As a Cannabis Withdrawal Symptommentioning
confidence: 99%
“…Analogous results were obtained in the ultrasonic vocalization emission test, which measures the number of stress-induced vocalizations emitted by rat pups removed from their nest . If confirmed in further behavioral models, these findings would suggest that inhibition of intracellular FAAH activity might offer an innovative target for the treatment of anxiety , which is also a feature of marijuana withdrawal (Kouri et al, 1999;Kouri and Pope, 2000;Budney et al, 2003).…”
Section: Behavioral Effects Of Faah Inhibitorsmentioning
confidence: 82%
“…The latter consists of a constellation of symptoms similar to those seen with nicotine withdrawal, which include irritability, sleep difficulty, decreased appetite, weight loss, and increased anger and irritability (Kouri et al, 1999;Kouri and Pope, 2000;Budney et al, 2003). There have been few pharmacological attempts to alleviate this syndrome (McRae et al, 2003), but one approach using oral D 9 -THC has recently shown significant promise (Haney et al, 2004).…”
Section: Discussionmentioning
confidence: 99%